BioNTech (NASDAQ:BNTX) shares fell Friday after the company said it had been informed by partner OncoC4 that FDA placed ...
The FDA approved a wearable tumor-treating fields (TTFields) device (Optune Lua) for concurrent use with a PD-1/PD-L1 ...
A new drug combo recently approved by the Food & Drug Administration can halt lung cancer in its treacherous tracks — for ...
The FDA has implemented a partial hold on a phase 3 non-small cell lung cancer trial run by BioNTech and OncoC4 after seeing ...
When you think of lung cancer treatment, what comes to mind—chemotherapy, radiation, surgery? While these can be crucial, ...
What’s more, AM-101 improved radiation treatment, slowing down the growth of NSCLC subcutaneous xenograft tumors in mice, by ...
Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...
The research highlights how some chronic conditions, such as chronic obstructive pulmonary disease (COPD) and asthma, can ...
Research shows regular physical activity can significantly improve quality of life for lung cancer patients. This includes ...
Telehealth services contributed to earlier diagnosis -- and better care -- for lung cancer patients. The better access you ...
At the moment, there’s just not enough data to understand what’s happened to the tens of thousands of missing cancer cases, ...
The move is a blow to Gilead’s cancer portfolio. Trodelvy, an antibody-drug conjugate granted accelerated approval for ...